FENC
NASDAQ · Biotechnology
Fennec Pharmaceuticals Inc
$7.84
+0.18 (+2.35%)
Open$7.75
Previous Close$7.66
Day High$7.95
Day Low$7.55
52W High$28.64
52W Low$19.99
Volume—
Avg Volume363.1K
Market Cap267.66M
P/E Ratio52.01
EPS$0.49
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+280.1% upside
Current
$7.84
$7.84
Target
$29.80
$29.80
$21.84
$29.80 avg
$37.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 74.30M | 77.18M | 58.63M |
| Net Income | -6,101,542 | -7,191,772 | -4,667,510 |
| Profit Margin | -8.2% | -9.3% | -8.0% |
| EBITDA | -9,610,170 | -10,191,915 | -7,485,493 |
| Free Cash Flow | -4,689,819 | -4,353,916 | -4,382,896 |
| Rev Growth | -7.2% | -5.1% | +12.7% |
| Debt/Equity | 0.51 | 0.45 | 0.53 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |